â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ“  **LAYER 5 â€” SYNTHESIS**
    Gemini synthesising 3 completed step(s)...
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ”¬ **QUERY**    : Identify genes associated with Spinal Muscular Atrophy (SMA), find their disease relationships, and gather supporting experimental evidence.
ğŸ¤– **MODEL**    : gemini-2.5-pro
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

## ğŸ¯ Direct Answer
The gene `ATP7A` has a `Moderate` association with X-linked distal spinal muscular atrophy type 3, according to ClinGen's Charcot-Marie-Tooth Disease Gene Curation Expert Panel. While this provides a specific genetic link, the broader research landscape focuses on clinical guidelines for genetic testing and the central biological mechanism of RNA splicing, which is a key area for further investigation.

## ğŸ§¬ Gene & Biological Context
ClinGen data provides a specific gene-disease validity classification for a subtype of Spinal Muscular Atrophy. The gene `ATP7A` is linked to "X-linked distal spinal muscular atrophy type 3" (MONDO:0010338). This relationship is classified as `Moderate` based on the ClinGen SOP9 framework, as of January 2023. This classification indicates there is a notable, but not yet definitive, level of evidence supporting the role of `ATP7A` in the pathogenesis of this specific X-linked form of SMA.

## ğŸ“š Current Research Landscape
The current landscape, based on the provided data, is dominated by clinical consensus rather than novel experimental findings. No recent preprints were identified on bioRxiv. Instead, author groups like "The Expert Consensus Group For Preimplantation Genetic Testing For Spinal Muscular Atrophy" are focused on standardizing genetic testing protocols. Another key theme is the evolution of clinical practice, with work centered on updating international care recommendations to incorporate the availability of new disease-modifying treatments (DMTs).

## ğŸ”¬ Knowledge Graph Connections
The Open Research Knowledge Graph (ORKG) connects Spinal Muscular Atrophy to core biological processes. The key concepts identified are "regulation of RNA splicing" and "alternative nuclear mRNA splicing, via spliceosome". These semantic links are significant because they highlight that the central mechanism underpinning SMA research is the processing of RNA. This suggests a primary research direction: investigating how genetic factors, including established genes like SMN1/SMN2 and newly implicated ones like `ATP7A`, modulate or disrupt these specific RNA splicing pathways to cause disease.

## ğŸ‘¤ Key Researchers to Follow
The provided data identifies influential consensus groups rather than individual researchers. These groups are driving clinical guidelines and standards of care in the field.

1.  **The Expert Consensus Group For Preimplantation Genetic Testing For Spinal Muscular Atrophy** â€” H-index: 1 | Citations: 2 | Institution: N/A
2.  **The 2018 international care recommendations for spinal muscular atrophy (SMA) were published prior to the availability of disease-modifying treatments (DMTs)** â€” H-index: 0 | Citations: 0 | Institution: N/A

No individual authors from recent preprints were identified as active in this specific data set.